Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy

Fig. 1

EBER1/2 and PABPC1 expression in NPC samples. a,c, and (e) 95%, 100%, and 0% for EBER1/2 with high expression in specimens 30 and 109 and negative expression in specimen 19, respectively; (b), (d), and (f) 55%, 0%, and 20% for PABPC1 having high-expression in specimen 30, low-expression in specimens 109 and 19, respectively. (Clinical and pathological characteristics of specimens 30, 109, and 19 are represented in Supplemental Table 1)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us